Latest Period
Q2 2026
Security Snapshot
AVANOS MEDICAL, INC. - Common Stock (AVNS) Institutional Ownership
CUSIP: 05350V106
13F Institutional Holders and Ownership History from Q1 2016 to Q2 2026
Institutions Reporting
281
Shares (Excl. Options)
43,621,407
Price
$24.88
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- AVNS
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 43,621,407
- Total 13F value
- $1,082,773,770
- Portfolio coverage rank
- 0.01%
- Share change
- -1,210,925
- Value change
- +$142,426,236
- Number of holders
- 281
- Shares outstanding
- 46,883,900
- SEC-reported price per share
- $24.99
- Insider filing price
- $24.99
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- AVNS - AVANOS MEDICAL, INC. - Common Stock is tracked under CUSIP 05350V106.
- 281 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 250 to 281 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $628,900,491 to $1,082,773,770.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 281 institutions filings for Q2 2026.
Security key
05350V106
Latest holder period
Q2 2026
13F holders
281
13D/G owners
5
CIK / CUSIP context first
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 05350V106:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
AVNS
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 15% | $84,305,460 | 6,826,353 | BlackRock, Inc. | 31 Mar 2025 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5% | $58,323,572 | 2,344,195 | Vanguard Capital Management | 30 Jun 2026 | |||
| DIMENSIONAL FUND ADVISORS LP | 4.6% | -10% | $24,230,152 | -$2,191,104 | 2,157,531 | -8.3% | Dimensional Fund Advisors LP | 31 Dec 2025 |
| ARMISTICE CAPITAL, LLC | 4.3% | -37% | $29,060,000 | -$17,436,000 | 2,000,000 | -38% | Armistice Capital, LLC | 31 Mar 2026 |
| T. Rowe Price Investment Management, Inc. | 3.7% | -65% | $24,752,000 | -$52,704,175 | 1,703,510 | -68% | T. Rowe Price Investment Management, Inc. | 30 Apr 2026 |
As of 30 Jun 2026, 281 institutional investors reported holding 43,621,407 shares of AVANOS MEDICAL, INC. - Common Stock (AVNS). This represents 93% of the company’s total 46,883,900 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
68%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 16% | 7,468,794 | +9.1% | 0% | $185,823,601 |
| NEXPOINT ASSET MANAGEMENT, L.P. | 4.6% | 2,177,366 | 3.6% | $54,172,866 | |
| STATE STREET CORP | 4.3% | 2,010,691 | +1.9% | 0% | $50,025,992 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.3% | 1,993,794 | +1.1% | 0% | $49,605,595 |
| TIG Advisors, LLC | 3.6% | 1,668,329 | 1.9% | $41,508,026 | |
| MILLENNIUM MANAGEMENT LLC | 3.3% | 1,524,553 | +10927% | 0.03% | $37,930,879 |
| First Trust Capital Management L.P. | 2.5% | 1,184,190 | 1.7% | $29,462,647 | |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5% | 1,181,164 | +7.9% | 0% | $29,392,658 |
| JPMORGAN CHASE & CO | 2.3% | 1,099,770 | +338% | 0% | $27,417,266 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2% | 946,344 | -11% | 0% | $23,545,039 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2% | 937,205 | -24% | 0% | $23,317,660 |
| AQR Arbitrage LLC | 1.9% | 895,333 | 0.32% | $22,275,885 | |
| FIL Ltd | 1.7% | 815,000 | 0.01% | $20,277,200 | |
| WATER ISLAND CAPITAL LLC | 1.7% | 799,002 | 2.1% | $19,879,170 | |
| GOLDMAN SACHS GROUP INC | 1.6% | 765,416 | +59% | 0% | $19,043,550 |
| Polar Asset Management Partners Inc. | 1.6% | 751,639 | 0.34% | $18,700,778 | |
| Pentwater Capital Management LP | 1.6% | 750,000 | 0.15% | $18,660,000 | |
| Balyasny Asset Management L.P. | 1.6% | 739,829 | 0.03% | $18,406,946 | |
| Sand Grove Capital Management LLP | 1.5% | 722,880 | 5% | $17,985,254 | |
| Thrivent Financial for Lutherans | 1.4% | 677,675 | -43% | 0.03% | $16,861,000 |
| Samson Rock Capital LLP | 1.3% | 600,000 | 33% | $14,928,000 | |
| Qube Research & Technologies Ltd | 1.2% | 554,350 | +328% | 0.02% | $13,792,228 |
| NORTHERN TRUST CORP | 1.1% | 523,070 | +6.9% | 0% | $13,013,981 |
| MORGAN STANLEY | 1% | 472,644 | -43% | 0% | $11,759,419 |
| ALPINE ASSOCIATES MANAGEMENT INC. | 0.92% | 432,621 | 0.67% | $10,763,609 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
42
Latest
Q2 2026
Rows shown
1-25 of 42
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 43,621,407 | $1,082,773,770 | +$142,426,236 | $24.88 | 281 |
| 2026 Q1 | 44,909,423 | $628,900,491 | -$3,160,392 | $14.01 | 250 |
| 2025 Q4 | 45,384,712 | $509,776,376 | +$5,467,835 | $11.23 | 272 |
| 2025 Q3 | 44,915,629 | $519,212,625 | -$456,743 | $11.56 | 269 |
| 2025 Q2 | 44,711,937 | $547,287,477 | +$14,185,298 | $12.24 | 279 |
| 2025 Q1 | 43,396,946 | $623,274,490 | -$6,741,914 | $14.33 | 275 |
| 2024 Q4 | 43,159,764 | $687,053,030 | -$348,352 | $15.92 | 253 |
| 2024 Q3 | 42,887,071 | $1,030,142,636 | +$14,845,110 | $24.03 | 257 |
| 2024 Q2 | 42,331,138 | $843,184,184 | -$19,844,468 | $19.92 | 254 |
| 2024 Q1 | 43,394,488 | $863,829,555 | -$12,610,070 | $19.91 | 255 |
| 2023 Q4 | 43,936,227 | $986,177,329 | +$6,301,621 | $22.43 | 261 |
| 2023 Q3 | 43,653,986 | $883,886,301 | -$24,810,694 | $20.22 | 251 |
| 2023 Q2 | 44,367,274 | $1,134,245,375 | +$6,577,133 | $25.56 | 267 |
| 2023 Q1 | 43,807,927 | $1,302,667,520 | +$18,327,231 | $29.74 | 278 |
| 2022 Q4 | 43,474,984 | $1,176,504,936 | +$5,615,427 | $27.06 | 274 |
| 2022 Q3 | 43,372,951 | $944,662,406 | -$2,543,596 | $21.78 | 218 |
| 2022 Q2 | 43,323,037 | $1,184,314,252 | -$13,685,481 | $27.34 | 227 |
| 2022 Q1 | 43,970,678 | $1,472,010,622 | +$2,331,652 | $33.50 | 252 |
| 2021 Q4 | 43,852,763 | $1,519,830,657 | +$2,873,575 | $34.67 | 251 |
| 2021 Q3 | 43,701,330 | $1,363,473,910 | -$25,618,497 | $31.20 | 229 |
| 2021 Q2 | 44,393,122 | $1,614,401,834 | +$1,417,948 | $36.37 | 239 |
| 2021 Q1 | 44,092,800 | $1,928,597,642 | -$45,329,737 | $43.74 | 251 |
| 2020 Q4 | 45,157,960 | $2,071,803,289 | -$25,305,709 | $45.88 | 240 |
| 2020 Q3 | 45,956,879 | $1,526,673,060 | -$9,601,150 | $33.22 | 230 |
| 2020 Q2 | 46,293,558 | $1,360,488,473 | +$21,246,989 | $29.39 | 233 |